Robin Mogg
- Virology top 0.5%
- HIV Research and Treatment 9
- Immunology top 5%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 5
- Epidemiology top 5%
- Neurology top 5%
-
- Cancer Immunotherapy and Biomarkers 8
-
- Statistical Methods in Clinical Trials 6
-
- Hepatitis C virus research 5
-
- Allergic Rhinitis and Sensitization 4
-
- Cancer Genomics and Diagnostics 4
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Co-authors
- Devan V. MehrotraDanilo R. CasimiroMichael RobertsonJavier R. LamaDavid LiMichael MarmorLawrence CoreyCarlos del Rı́o
- Journals
- Journal of Clinical Oncology (7 papers)Statistics in Medicine (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Robin Mogg
43 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Virology 853
- Immunology 795
- Infectious Diseases 596
- Epidemiology 556
- Neurology 239
Countries citing papers authored by Robin Mogg
This map shows the geographic impact of Robin Mogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Mogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Mogg more than expected).
Fields of papers citing papers by Robin Mogg
This network shows the impact of papers produced by Robin Mogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Mogg. The network helps show where Robin Mogg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robin Mogg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2022 | 54 | |
| 3 | 2021 | 115 | |
| 4 | 2021 | 29 | |
| 5 | 2021 | 8 | |
| 6 | 2018 | 34 | |
| 7 | Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 studybreakdown → | 2018 | 277 |
| 8 | 2017 | 9 | |
| 9 | 2016 | 18 | |
| 10 | 2016 | 54 | |
| 11 | Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammationbreakdown → | 2013 | 304 |
| 12 | 2011 | 4 | |
| 13 | 2009 | 8 | |
| 14 | 2009 | 44 | |
| 15 | 2008 | 15 | |
| 16 | Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialbreakdown → | 2008 | 1215 |
| 17 | 2007 | 60 | |
| 18 | 2006 | 26 | |
| 19 | 2006 | 7 | |
| 20 | 2006 | 15 |
About Robin Mogg
Robin Mogg is a scholar working on Virology, Statistics and Probability and Otorhinolaryngology, having authored 44 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Statistical Methods in Clinical Trials (6 papers), HIV/AIDS drug development and treatment (5 papers), Hepatitis C virus research (5 papers), Allergic Rhinitis and Sensitization (4 papers), Cancer Genomics and Diagnostics (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Virology (853 citations), Immunology (795 citations) and Infectious Diseases (596 citations). Robin Mogg has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Devan V. Mehrotra, Danilo R. Casimiro, Michael Robertson, Javier R. Lama, David Li, Michael Marmor, Lawrence Corey, Carlos del Rı́o, Ann Duerr and Keith Gottesdiener. Their work appears in journals such as Journal of Clinical Oncology, Statistics in Medicine, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.